| NCT03301883 | Hoffmann-La Roche | Juvenile Idiopathic Arthritis | 2018-04-26 | PHASE4 |
| NCT07509645 | Capital Medical University | Ischemic Stroke | 2026-04-22 | PHASE3 |
| NCT05346666 | Damanhour University|Tanta University|Principal Investigator Mohanad Omar Ahmed, Msc Pharmacy Practice Department- Horus University | Epilepsy | 2022-06-25 | PHASE3 |
| NCT00996606 | Hoffmann-La Roche | Rheumatoid Arthritis | 2009-10 | PHASE3 |
| NCT04359667 | University Hospital for Infectious Diseases, Croatia | COVID-19|Severe Pneumonia | 2020-06-16 | |
| NCT06442709 | Affiliated Hospital of Nantong University | Nasopharyngeal Carcinoma | 2021-08-01 | NA |
| NCT05927571 | Genentech, Inc. | Relapsed or Refractory Multiple Myeloma | 2023-08-10 | PHASE1 |
| NCT05874505 | Assistance Publique - H?pitaux de Paris | Behcet´s Uveitis | 2023-07 | PHASE2 |
| NCT03511118 | Duke University|The Emmes Company, LLC|Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) | Lactating Women on Select DOI|Breastfed Infants of Mothers on Select DOI | 2018-10-04 | |
| NCT05364424 | Hoffmann-La Roche | Diffuse Large B-Cell Lymphoma (DLBCL) | 2022-11-04 | PHASE1 |
| NCT01331837 | Hoffmann-La Roche | Rheumatoid Arthritis | 2011-08-02 | PHASE4 |
| NCT01034137 | Hoffmann-La Roche | Rheumatoid Arthritis | 2010-01 | PHASE3 |
| NCT04561986 | Vastra Gotaland Region|Karolinska University Hospital|Uppsala University Hospital|Skane University Hospital|The Swedish Research Council|Hospital del Mar|Hospital Universitario Doctor Peset|Complexo Hospitalario Universitario de A Coru?a|Hospital Universitario Marqués de Valdecilla | Antibody-mediated Rejection | 2022-02-01 | PHASE3 |
| NCT03155347 | Hoffmann-La Roche | Rheumatoid Arthritis | 2017-08-02 | PHASE3 |
| NCT03539484 | Hoffmann-La Roche | Solid Tumors | 2018-07-04 | PHASE1 |
| NCT04361552 | Emory University|National Cancer Institute (NCI) | Cerebrovascular Accident|Chronic Obstructive Pulmonary Disease|Chronic Renal Failure|Coronary Artery Disease|Diabetes Mellitus|Malignant Neoplasm|SARS Coronavirus 2 Infection | 2020-04-07 | PHASE3 |
| NCT02778789 | University of Erlangen-Nürnberg Medical School | Rheumatoid Arthritis | 2015-10 | |
| NCT01209689 | Hoffmann-La Roche | Spondylitis, Ankylosing | 2010-10 | PHASE3 |
| NCT00144560 | Chugai Pharmaceutical | Rheumatoid Arthritis | 2005-02 | NA |
| NCT01734993 | Hoffmann-La Roche | Rheumatoid Arthritis | 2012-10 | PHASE3 |
| NCT02165345 | Hoffmann-La Roche | Juvenile Idiopathic Arthritis | 2014-07-16 | PHASE1 |
| NCT01782235 | University Hospital, Strasbourg, France | Primary Sj?gren´s Syndrome (pSS) | 2013-07-24 | PHASE2|PHASE3 |
| NCT07263776 | Capital Medical University | Acute Ischemic Stroke | 2025-12-05 | PHASE3 |
| NCT06233357 | University of Ulm | COVID-19|Outcome, Fatal|Tocilizumab|Interleukin 6|Critically Ill | 2021-08-01 | |
| NCT01450137 | Insel Gruppe AG, University Hospital Bern|University of Bern|Roche Pharma AG | Giant Cell Arteritis | 2011-09 | PHASE2 |
| NCT03467256 | Federal Research Institute of Pediatric Hematology, Oncology and Immunology | B-cell Acute Lymphoblastic Leukemia|Acute Lymphocytic Leukemia, Pediatric | 2018-05-14 | PHASE1|PHASE2 |
| NCT05855122 | The First Affiliated Hospital of Soochow University | Multiple Myeloma | 2023-04-17 | PHASE4 |
| NCT02453256 | Hoffmann-La Roche | Systemic Sclerosis | 2015-11-20 | PHASE3 |
| NCT00380601 | Chugai Pharmaceutical | Rheumatoid Arthritis | 2006-05 | PHASE3 |
| NCT01655381 | Hoffmann-La Roche | Rheumatoid Arthritis | 2012-04 | PHASE3 |
| NCT01904292 | Hoffmann-La Roche | Juvenile Idiopathic Arthritis | 2013-08-15 | PHASE1 |
| NCT00144625 | Chugai Pharmaceutical | Polyarticular Juvenile Idiopathic Arthritis | 2005-02 | PHASE3 |
| NCT01941940 | Hoffmann-La Roche | Rheumatoid Arthritis | 2013-09-05 | PHASE3 |
| NCT02336048 | Hoffmann-La Roche | B-Cell Chronic Lymphocytic Leukemia | 2015-06-26 | PHASE1 |
| NCT04980222 | Hoffmann-La Roche | Lymphoma | 2022-03-22 | PHASE2 |
| NCT02007239 | Children´s Hospital of Philadelphia | Hemophagocytic Lymphohistiocytosis | 2013-12 | PHASE2 |
| NCT00144573 | Chugai Pharmaceutical | Rheumatoid Arthritis | 2005-01 | NA |
| NCT03677141 | Hoffmann-La Roche | B-cell Non-Hodgkin Lymphoma | 2019-03-08 | PHASE1|PHASE2 |
| NCT04315480 | Università Politecnica delle Marche|Azienda Ospedaliera Ospedali Riuniti Marche Nord | SARS Pneumonia | 2020-03-12 | PHASE2 |
| NCT01063062 | Hoffmann-La Roche | Rheumatoid Arthritis | 2010-02-28 | PHASE3 |
| NCT02034474 | New York State Psychiatric Institute|Stanley Medical Research Institute | Schizophrenia|Schizoaffective Disorder | 2014-02 | PHASE4 |
| NCT02906371 | University of Pennsylvania|Children´s Hospital of Philadelphia | Lymphoblastic Leukemia, Acute, Childhood | 2016-08 | PHASE1 |
| NCT04529863 | Brigham and Women´s Hospital|National Institute on Aging (NIA)|Rutgers University|Johns Hopkins University | Rheumatoid Arthritis | 2020-08-17 | |
| NCT02676947 | Papworth Hospital NHS Foundation Trust|Roche Pharma AG|National Institute for Health Research, United Kingdom | Pulmonary Arterial Hypertension | 2016-01 | PHASE2 |
| NCT01791842 | Hospices Civils de Lyon | Fibrous Dysplasia of Bone | 2013-05-05 | PHASE2 |
| NCT02043548 | Chester Oddis|Genentech, Inc. | Dermatomyositis|Polymyositis | 2014-10-01 | PHASE2 |
| NCT03062579 | Fu-Dong Shi | Neuromyelitis Optica Spectrum Disorders|Neuromyelitis Optica|Devic´s Disease | 2017-02-01 | PHASE1|PHASE2 |
| NCT05394909 | Azienda USL Reggio Emilia - IRCCS | GCA|TOCILIZUMAB|Glucocorticoids|PET | 2020-02-07 | |
| NCT01995201 | Hoffmann-La Roche | Rheumatoid Arthritis | 2013-09 | PHASE3 |
| NCT07392814 | Nantes University Hospital | Leukemia Acute Myeloid - AML | 2026-03-10 | PHASE1 |
| NCT04873141 | Shaheed Zulfiqar Ali Bhutto Medical University | Cytokine Release Syndrome|Covid-19 Pneumonia | 2020-04-28 | |
| NCT05845723 | Peking Union Medical College Hospital | Aneurysm|Behcet Syndrome, Vascular Type | 2023-06-01 | PHASE2 |
| NCT01734382 | Hoffmann-La Roche | Juvenile Idiopathic Arthritis | 2013-06-10 | PHASE4 |
| NCT05035589 | Sciberras, Stephen M.D.|Mater Dei Hospital, Malta | COVID-19 Pneumonia|ARDS | 2021-09-20 | |
| NCT02765074 | Centre Hospitalier Régional d´Orléans|Rennes University Hospital | Rheumatoid Arthritis | 2016-06-30 | PHASE4 |
| NCT05091424 | Hoffmann-La Roche | Chronic Lymphocytic Leukemia | 2022-03-07 | PHASE1 |
| NCT02837146 | Maria Stoenoiu | Rheumatoid Arthritis | 2015-12 | PHASE3 |
| NCT04077723 | Hoffmann-La Roche | Lymphoma, Non-Hodgkin | 2019-08-13 | PHASE1|PHASE2 |
| NCT00106522 | Hoffmann-La Roche | Rheumatoid Arthritis | 2005-05 | PHASE3 |
| NCT04842981 | University of Southern Denmark|Odense University Hospital|Esbjerg Hospital - University Hospital of Southern Denmark|King Christian X?Hospital for Rheumatic Diseases|Sygehus Lillebaelt|Odense Patient Data Explorative Network | Arthritis, Rheumatoid|Interaction | 2021-05-25 | PHASE1|PHASE2 |
| NCT02293837 | National Institute of Allergy and Infectious Diseases (NIAID)|Immune Tolerance Network (ITN)|PPD Development, LP|Rho Federal Systems Division, Inc. | Type 1 Diabetes Mellitus|New-onset Type 1 Diabetes Mellitus|T1DM|T1D | 2015-03-12 | PHASE2 |
| NCT03075696 | Hoffmann-La Roche | Non-Hodgkin´s Lymphoma | 2017-02-21 | PHASE1|PHASE2 |
| NCT01353859 | Hoffmann-La Roche | Rheumatoid Arthritis | 2011-03 | PHASE3 |
| NCT00721123 | Hoffmann-La Roche | Rheumatoid Arthritis | 2005-08 | PHASE3 |
| NCT01665430 | Hoffmann-La Roche | Rheumatoid Arthritis | 2012-07 | PHASE3 |
| NCT03601611 | Herlev Hospital|Bristol-Myers Squibb | Solid Tumor|Colitis|Arthritis | 2019-01-01 | NA |
| NCT01579006 | Hoffmann-La Roche|Clalit Health Services | Rheumatoid Arthritis | 2012-05 | |
| NCT04940299 | M.D. Anderson Cancer Center | Clinical Stage III Cutaneous Melanoma AJCC v8|Clinical Stage IV Cutaneous Melanoma AJCC v8|Locally Advanced Bladder Carcinoma|Locally Advanced Bladder Urothelial Carcinoma|Locally Advanced Lung Non-Small Cell Carcinoma|Locally Advanced Renal Pelvis Carcinoma|Locally Advanced Renal Pelvis Urothelial Carcinoma|Locally Advanced Ureter Urothelial Carcinoma|Locally Advanced Urethral Urothelial Carcinoma|Malignant Solid Neoplasm|Metastatic Bladder Carcinoma|Metastatic Bladder Urothelial Carcinoma|Metastatic Lung Non-Small Cell Carcinoma|Metastatic Melanoma|Metastatic Renal Pelvis Urothelial Carcinoma|Metastatic Ureter Urothelial Carcinoma|Metastatic Urethral Carcinoma|Metastatic Urethral Urothelial Carcinoma|Pathologic Stage III Cutaneous Melanoma AJCC v8|Pathologic Stage IIIA Cutaneous Melanoma AJCC v8|Pathologic Stage IIIB Cutaneous Melanoma AJCC v8|Pathologic Stage IIIC Cutaneous Melanoma AJCC v8|Pathologic Stage IIID Cutaneous Melanoma AJCC v8|Pathologic Stage IV Cutaneous Melanoma AJCC v8|Stage III Bladder Cancer AJCC v8|Stage III Lung Cancer AJCC v8|Stage III Renal Pelvis Cancer AJCC v8|Stage III Ureter Cancer AJCC v8|Stage III Urethral Cancer AJCC v8|Stage IIIA Bladder Cancer AJCC v8|Stage IIIA Lung Cancer AJCC v8|Stage IIIB Bladder Cancer AJCC v8|Stage IIIB Lung Cancer AJCC v8|Stage IIIC Lung Cancer AJCC v8|Stage IV Bladder Cancer AJCC v8|Stage IV Lung Cancer AJCC v6|Stage IV Renal Pelvis Cancer AJCC v8|Stage IV Ureter Cancer AJCC v8|Stage IV Urethral Cancer AJCC v8|Stage IVA Lung Cancer AJCC v8|Stage IVB Lung Cancer AJCC v8|Unresectable Melanoma | 2021-09-23 | PHASE2 |
| NCT01163747 | Genentech, Inc. | Rheumatoid Arthritis | 2010-09 | PHASE4 |
| NCT00144547 | Chugai Pharmaceutical | Rheumatoid Arthritis | 2004-04 | PHASE3 |
| NCT02721004 | Hoffmann-La Roche | Rheumatoid Arthritis | 2009-03 | |
| NCT04564001 | Assistance Publique - H?pitaux de Paris | Takayasu Arteritis | 2020-09 | PHASE2 |
| NCT01649804 | Hoffmann-La Roche | Rheumatoid Arthritis | 2012-07 | PHASE3 |
| NCT04779047 | October 6 University|Beni-Suef University | Covid19|Pneumonia | 2020-10-01 | PHASE4 |
| NCT02908217 | University Hospital, Brest|Roche Chugai | Polymyalgia Rheumatica | 2017-02-15 | PHASE3 |
| NCT00642460 | Hoffmann-La Roche | Juvenile Idiopathic Arthritis | 2008-05 | PHASE3 |
| NCT00531817 | Hoffmann-La Roche | Rheumatoid Arthritis | 2007-10 | PHASE3 |
| NCT05219513 | Hoffmann-La Roche | Lymphoma, Non-Hodgkin | 2022-02-18 | PHASE1 |
| NCT06016517 | Tufts Medical Center | Arthritis, Rheumatoid | 2026-05-01 | |
| NCT03564340 | Regeneron Pharmaceuticals | Recurrent Ovarian Cancer|Recurrent Fallopian Tube Cancer|Recurrent Primary Peritoneal Cancer|Recurrent Endometrial Cancer|Endometrial Cancer|Low-grade Serous Ovarian Cancer | 2018-05-21 | PHASE1|PHASE2 |
| NCT06043674 | Christine Ryan|Genentech, Inc.|Loxo Oncology, Inc.|Eli Lilly and Company | Chronic Lymphocytic Leukemia|Richter´s Transformation | 2024-01-22 | PHASE2 |
| NCT04239196 | Centre Hospitalier National d´Ophtalmologie des Quinze-Vingts|Roche Chugai | Giant Cell Arteritis|Optic Ischaemic Neuropathy | 2020-09-10 | PHASE2 |
| NCT04394182 | Fundacion GenesisCare|Hospital La Milagrosa|Hospital Vithas Valencia Consuelo | Pneumonia, Viral|Cytokine Storm | 2020-04-21 | NA |
| NCT05640271 | University of Chicago | Sickle Cell Disease|Acute Chest Syndrome | 2023-04-10 | PHASE2 |
| NCT04380818 | Grupo de Investigación Clínica en Oncología Radioterapia|Hospital Universitario Madrid Sanchinarro|Hospital del Mar|Hospital Universitari Sant Joan de Reus | Pneumonia, Viral | 2020-06-05 | NA |
| NCT05835986 | Hoffmann-La Roche | Systemic Lupus Erythematosus | 2023-12-18 | PHASE1 |
| NCT04363853 | Instituto Nacional de Cancerologia de Mexico|Roche Pharma AG | Sars-CoV2 | 2020-06-01 | PHASE2 |
| NCT04007029 | Jonsson Comprehensive Cancer Center|Parker Institute for Cancer Immunotherapy | CD19 Positive|CD20 Positive|Recurrent Chronic Lymphocytic Leukemia|Recurrent Diffuse Large B-Cell Lymphoma|Recurrent Follicular Lymphoma|Recurrent Mantle Cell Lymphoma|Recurrent Primary Mediastinal (Thymic) Large B-Cell Cell Lymphoma|Recurrent Small Lymphocytic Lymphoma|Refractory Chronic Lymphocytic Leukemia|Refractory Diffuse Large B-Cell Lymphoma|Refractory Follicular Lymphoma|Refractory Mantle Cell Lymphoma|Refractory Primary Mediastinal (Thymic) Large B-Cell Cell Lymphoma|Refractory Small Lymphocytic Lymphoma | 2019-10-04 | PHASE1 |
| NCT05609630 | AbbVie | Juvenile Idiopathic Arthritis | 2023-10-02 | PHASE3 |
| NCT03893136 | Shanghai Zhongshan Hospital | Takayasu Arteritis|Mechanisms, Defense|Pregnancy Related|Treatment Refusal|Outcome | 2016-11-01 | |
| NCT04335305 | MedSIR | COVID-19|Pneumonia, Viral | 2020-04-09 | PHASE2 |
| NCT04347031 | Burnasyan Federal Medical Biophysical Center | Pneumonia, Viral|Respiratory Failure | 2020-04-08 | PHASE2|PHASE3 |
| NCT01717170 | University of Nebraska | Intermediate Uveitis|Posterior Uveitis|Pan-uveitis | 2013-03 | PHASE1|PHASE2 |
| NCT06654882 | Duke University|Patient-Centered Outcomes Research Institute | Polyarticular Course Juvenile Idiopathic Arthritis (JIA) | 2026-01-09 | PHASE3 |
| NCT01002781 | Tel-Aviv Sourasky Medical Center|Rambam Health Care Campus|Assaf-Harofeh Medical Center|Bnai Zion Medical Center | Adult´s Still Disease | 2009-11 | PHASE2 |
| NCT01245439 | Hoffmann-La Roche | Rheumatoid Arthritis | 2011-09 | PHASE3 |
| NCT03350633 | Tianjin Medical University General Hospital | Neuromyelitis Optica Spectrum Disorders|Neuromyelitis Optica | 2017-11-01 | PHASE2|PHASE3 |
| NCT03215407 | Chinese PLA General Hospital | Rheumatoid Arthritis of Knee | 2017-08-01 | PHASE4 |
| NCT03263715 | Medical University of Vienna | Polymyalgia Rheumatica | 2017-11-24 | PHASE3 |
| NCT01332994 | Hoffmann-La Roche | Rheumatoid Arthritis | 2011-03 | PHASE3 |
| NCT00144586 | Chugai Pharmaceutical | Rheumatoid Arthritis | 2005-03 | PHASE3 |
| NCT01232569 | Hoffmann-La Roche | Rheumatoid Arthritis | 2011-03 | PHASE3 |
| NCT01791153 | Hoffmann-La Roche | Giant Cell Arteritis | 2013-07-22 | PHASE3 |
| NCT03677154 | Hoffmann-La Roche | Diffuse Large B-cell Lymphoma | 2019-05-23 | PHASE1|PHASE2 |
| NCT01617005 | Hoffmann-La Roche | Rheumatoid Arthritis | 2012-05 | |
| NCT06941376 | University of Pennsylvania | Relapsing Polychondritis | 2025-08-01 | PHASE2 |
| NCT06372574 | Genentech, Inc. | Refractory Cancer|Recurrent Cancer|Solid Tumor, Adult | 2024-09-30 | PHASE1 |
| NCT01717859 | University of California, Los Angeles|Genentech, Inc. | Rheumatoid Arthritis | 2014-09 | PHASE4 |
| NCT04349410 | The Camelot Foundation | CoVid 19 Positive | 2020-04-11 | PHASE2|PHASE3 |
| NCT00951275 | Hoffmann-La Roche | Rheumatoid Arthritis | 2009-10-31 | PHASE3 |
| NCT01661140 | Hoffmann-La Roche | Rheumatoid Arthritis | 2012-09 | PHASE4 |
| NCT05082714 | University Hospital of Patras | COVID-19 | 2021-10-20 | NA |
| NCT04580121 | Hoffmann-La Roche | Acute Myeloid Leukemia | 2020-11-04 | PHASE1 |
| NCT01219933 | Hoffmann-La Roche | Rheumatoid Arthritis | 2011-01 | PHASE4 |
| NCT02101333 | Assistance Publique - H?pitaux de Paris|Chugai Pharmaceutical | TAKAYASU ARTERITIS | 2014-06-10 | PHASE3 |
| NCT05869955 | Juno Therapeutics, Inc., a Bristol-Myers Squibb Company|Bristol-Myers Squibb Services Unlimited Company | Systemic Lupus Erythematosus|Idiopathic Inflammatory Myopathy|Systemic Sclerosis|Rheumatoid Arthritis | 2023-09-13 | PHASE1 |
| NCT04408638 | Hoffmann-La Roche | Diffuse Large B-cell Lymphoma | 2021-02-23 | PHASE3 |
| NCT04616248 | University of Southern California|National Institutes of Health (NIH) | Anatomic Stage IV Breast Cancer AJCC v8|Metastatic Breast Carcinoma|Prognostic Stage IV Breast Cancer AJCC v8|Unresectable Breast Carcinoma|Metastatic Melanoma|Unresectable Melanoma|Cutaneous Squamous Cell Carcinoma|Merkel Cell Carcinoma|Soft Tissue Sarcoma|Bone Sarcoma|Sarcoma,Soft Tissue|Sarcoma of Bone|Basal Cell Carcinoma | 2023-01-09 | PHASE1 |
| NCT03863015 | Christian Hassager | Heart Arrest|Out-Of-Hospital Cardiac Arrest|Systemic Inflammatory Response Syndrome | 2019-03-04 | PHASE2 |
| NCT01044498 | Hoffmann-La Roche | Rheumatoid Arthritis | 2009-12 | PHASE3 |
| NCT04657302 | Hoffmann-La Roche | Lymphoma | 2021-01-08 | PHASE1 |
| NCT02174263 | Fred Hutchinson Cancer Center|National Cancer Institute (NCI) | Graft Versus Host Disease | 2016-02 | PHASE2 |
| NCT02573012 | Hoffmann-La Roche | Rheumatoid Arthritis | 2016-03-29 | PHASE4 |
| NCT02011334 | Hoffmann-La Roche | Rheumatoid Arthritis | 2014-07 | PHASE3 |
| NCT01693653 | NYU Langone Health|Genentech, Inc. | Behcet Syndrome | 2012-09 | PHASE2 |
| NCT05333302 | Belarusian Research Center for Pediatric Oncology, Hematology and Immunology | B-cell Acute Lymphoblastic Leukemia|Lymphoblastic B-Cell Lymphoma | 2020-10-26 | PHASE1 |
| NCT04524871 | Hoffmann-La Roche|Adagene Inc|Tempest Therapeutics|NiKang Therapeutics, Inc.|Immune-Onc Therapeutics | Advanced Liver Cancers | 2020-11-01 | PHASE1|PHASE2 |
| NCT02108600 | Flavio Vincenti | Late Complication From Kidney Transplant | 2014-06 | PHASE2 |
| NCT04403685 | Beneficência Portuguesa de S?o Paulo|Hospital do Coracao|Hospital Israelita Albert Einstein|Hospital Sirio-Libanes|Hospital Alem?o Oswaldo Cruz|Brazilian Research In Intensive Care Network|Hospital Moinhos de Vento|Brazilian Clinical Research Institute|Federal University of S?o Paulo | COVID|SARS Pneumonia|Cytokine Release Syndrome | 2020-05-08 | PHASE3 |
| NCT04320615 | Hoffmann-La Roche | COVID-19 Pneumonia | 2020-04-03 | PHASE3 |
| NCT05533775 | Hoffmann-La Roche | Mature B-Cell Non-Hodgkin Lymphoma | 2022-11-16 | PHASE1|PHASE2 |
| NCT00144612 | Chugai Pharmaceutical | Systemic Juvenile Idiopathic Arthritis | 2004-07 | PHASE3 |
| NCT03337698 | Hoffmann-La Roche | Carcinoma, Non-Small-Cell Lung | 2017-12-27 | PHASE1|PHASE2 |
| NCT05168475 | Cambridge University Hospitals NHS Foundation Trust | Giant Cell Arteritis|Takayasu Arteritis|Cogan Syndrome|Relapsing Polychondritis|Cryoglobulinemic Vasculitis|IgA Vasculitis|Polyarteritis Nodosa|Cutaneous Polyarteritis Nodosa|Primary Angiitis of Central Nervous System | 2021-07-14 | PHASE2 |
| NCT00883753 | Hoffmann-La Roche | Rheumatoid Arthritis | 2009-03 | PHASE3 |
| NCT03533101 | Hospital Universitario Dr. Jose E. Gonzalez | Cytokine Release Syndrome|Stem Cell Transplant Complications | 2018-05-25 | PHASE1|PHASE2 |
| NCT04600141 | University of Sao Paulo|Conselho Nacional de Desenvolvimento Científico e Tecnológico | Covid19 | 2020-11-10 | PHASE3 |
| NCT04330638 | University Hospital, Ghent|Belgium Health Care Knowledge Centre | COVID-19 | 2020-04-03 | PHASE3 |
| NCT05233397 | Nationwide Children´s Hospital|Children´s Hospital Colorado | Adamantinomatous Craniopharyngioma|Recurrent Adamantinomatous Craniopharyngioma | 2022-12-16 | PHASE2 |
| NCT05279391 | Democritus University of Thrace | COVID-19 Severe Respiratory Failure | 2020-10-25 | NA |
| NCT02097524 | Regeneron Pharmaceuticals|Sanofi | Rheumatoid Arthritis | 2014-03 | PHASE1 |
| NCT02682823 | Hoffmann-La Roche | Rheumatoid Arthritis | 2016-03-21 | PHASE4 |
| NCT01904279 | Hoffmann-La Roche | Juvenile Idiopathic Arthritis | 2013-07 | PHASE1 |
| NCT05583617 | Hoffmann-La Roche | Multiple Myeloma | 2023-11-14 | PHASE1|PHASE2 |
| NCT06367517 | Medical University of Warsaw | Orbitopathy, Graves|Thyroid Eye Disease|Ophthalmopathy | 2021-05-20 | |
| NCT02552940 | Hoffmann-La Roche|nv Roche sa | Rheumatoid Arthritis | 2015-10-31 | |
| NCT04616235 | Rigshospitalet, Denmark | Interleukin-6 Inhibition|Physical Stress|Appetitive Behavior | 2021-03-15 | NA |
| NCT01727206 | Ospedale San Raffaele | Erdheim-Chester Disease | 2012-11 | PHASE2 |
| NCT00144534 | Chugai Pharmaceutical | Rheumatoid Arthritis | 2004-06 | PHASE3 |
| NCT02648035 | Hoffmann-La Roche | Rheumatoid Arthritis | 2016-09-22 | |
| NCT03446209 | University Hospital Tuebingen | Familial Mediterranean Fever | 2018-04-23 | PHASE2 |
| NCT01297699 | Hospital Clinico Universitario de Santiago|Fundación Ramón Domínguez | Thyroid Associated Ophthalmopathies|Graves? Ophthalmopathy|Thyroid Eye Disease | 2012-03 | PHASE3 |
| NCT00810277 | Hoffmann-La Roche | Rheumatoid Arthritis | 2008-11-30 | PHASE3 |
| NCT01149057 | Hoffmann-La Roche|Clalit Health Services | Rheumatoid Arthritis | 2010-10 | PHASE4 |
| NCT04331808 | Assistance Publique - H?pitaux de Paris | Corona Virus Infection | 2020-03-30 | PHASE2 |
| NCT05155345 | Hoffmann-La Roche | Systemic Lupus Erythematosus | 2022-01-11 | PHASE1 |
| NCT04551352 | Hoffmann-La Roche | Cutaneous Melanoma|Uveal Melanoma|Mucosal Melanoma | 2020-10-28 | PHASE1 |
| NCT01235507 | Hoffmann-La Roche | Rheumatoid Arthritis | 2011-02 | PHASE3 |
| NCT01772316 | Hoffmann-La Roche | Rheumatoid Arthritis | 2012-12 | PHASE3 |
| NCT06381661 | Assistance Publique - H?pitaux de Paris | Sepsis | 2026-05-01 | PHASE2 |
| NCT05129280 | Hoffmann-La Roche | Solid Tumors | 2022-01-25 | PHASE1 |
| NCT07570173 | Merck Sharp & Dohme LLC | B-cell Acute Lymphoblastic Leukemia | 2026-05-08 | PHASE2|PHASE3 |
| NCT04346355 | Azienda USL Reggio Emilia - IRCCS | COVID-19 Pneumonia | 2020-03-31 | PHASE2 |
| NCT05846789 | Kathy Miller|Genentech, Inc.|Breast Cancer Research Foundation|Susan G. Komen Breast Cancer Foundation | Metastatic Breast Cancer|Triple Negative Breast Cancer|Estrogen-receptor-low Breast Cancer | 2024-07-02 | PHASE2 |
| NCT03100253 | Mario Negri Institute for Pharmacological Research | Rheumatoid Arthritis | 2018-03-01 | PHASE4 |
| NCT01670045 | Hoffmann-La Roche | Rheumatoid Arthritis | 2012-03 | |
| NCT00868751 | Tufts Medical Center|Hoffmann-La Roche | Arthritis, Juvenile Rheumatoid|Still´s Disease, Juvenile Onset | 2009-03 | NA |
| NCT06238024 | Suzhou Municipal Hospital of Anhui Province|Xuanwu Hospital, Beijing | Interleukin-6|Ischemic Stroke|Endovascular Treatment | 2024-02-02 | PHASE2|PHASE3 |
| NCT01475162 | Medical College of Wisconsin | Acute Graft Versus Host Disease | 2011-08-08 | PHASE1|PHASE2 |
| NCT01727986 | Hoffmann-La Roche | Juvenile Idiopathic Arthritis | 2013-03 | PHASE3 |
| NCT01951170 | Hoffmann-La Roche | Rheumatoid Arthritis | 2013-11 | PHASE3 |
| NCT06721910 | University Hospital, Basel, Switzerland | Healthy|Glucagon Resistance|Amino Acid Change | 2025-01-15 | NA |
| NCT01242488 | UCB Pharma | Rheumatoid Arthritis | 2010-11 | PHASE2 |
| NCT00109408 | Hoffmann-La Roche | Rheumatoid Arthritis | 2005-07 | PHASE3 |
| NCT04321993 | Lisa Barrett|Nova Scotia Health Authority|Dalhousie University | COVID-19 | 2020-04-17 | PHASE2 |
| NCT05619744 | Hoffmann-La Roche | Small Cell Lung Cancer|Neuroendocrine Carcinoma | 2023-01-23 | PHASE1 |
| NCT03440892 | Vastra Gotaland Region | Rheumatoid Arthritis | 2017-11-01 | |
| NCT03726749 | Massachusetts General Hospital|Roche-Genentech | Giant Cell Arteritis | 2018-11-28 | PHASE4 |
| NCT04479358 | University of Chicago | COVID-19 | 2020-09-10 | PHASE2 |
| NCT06498089 | Shanghai Zhongshan Hospital | Takayasu Arteritis | 2024-06-28 | PHASE4 |
| NCT07108387 | National Institute of Allergy and Infectious Diseases (NIAID) | Giant Cell Arteritis (GCA) | 2025-12-11 | PHASE2 |
| NCT00144508 | Chugai Pharmaceutical | Rheumatoid Arthritis | 2003-03 | PHASE3 |
| NCT01089023 | Hoffmann-La Roche | Rheumatoid Arthritis | 2010-01 | PHASE4 |
| NCT01010503 | Hoffmann-La Roche | Rheumatoid Arthritis | 2009-06 | PHASE4 |
| NCT04335071 | Insel Gruppe AG, University Hospital Bern|Roche Pharma AG | SARS-CoV-2 Infection | 2020-04-26 | PHASE2 |
| NCT02888496 | University Hospital, Brest | Polymyalgia Rheumatica | 2015-01 | |
| NCT04361032 | Abderrahmane Mami Hospital|Eshmoun Clinical Research Center|Datametrix | COVID19|Intensive Care Unit | 2020-09-04 | PHASE3 |
| NCT04876534 | Fondazione IRCCS Ca´ Granda, Ospedale Maggiore Policlinico|Mauriziano Umberto I Hospital|Istituto Auxologico Italiano|Azienda Ospedaliera "Sant´Andrea"|Azienda Ospedaliero, Universitaria Pisana | Graves Ophthalmopathy | 2019-12-18 | PHASE2 |
| NCT04356937 | Massachusetts General Hospital|Genentech, Inc. | SARS-CoV 2 | 2020-04-20 | PHASE3 |
| NCT00144599 | Chugai Pharmaceutical | Systemic Juvenile Idiopathic Arthritis | 2004-05 | PHASE3 |
| NCT01455701 | Hoffmann-La Roche | Juvenile Idiopathic Arthritis | 2012-10-26 | PHASE1 |
| NCT04339712 | Hellenic Institute for the Study of Sepsis | COVID-19|Virus Diseases|Macrophage Activation Syndrome|Corona Virus Infection | 2020-04-02 | PHASE2 |
| NCT03745586 | Insel Gruppe AG, University Hospital Bern | Giant Cell Arteritis | 2018-12-01 | PHASE1|PHASE2 |
| NCT04924829 | Hospital Italiano de Buenos Aires | Severe COVID 19 Pneumonia|Tocilizumab | 2021-06-01 | |
| NCT01594424 | Cedars-Sinai Medical Center | End Stage Renal Disease (ESRD) | 2012-06 | PHASE1|PHASE2 |
| NCT02797769 | Hoffmann-La Roche | Rheumatoid Arthritis | 2016-06-02 | |
| NCT02843789 | Centre Hospitalier Universitaire de Besancon | Arthritis, Rheumatoid | 2013-03 | PHASE4 |
| NCT07006532 | Shahid Beheshti University of Medical Sciences | Kidney Transplant Rejection | 2025-01-01 | NA |
| NCT01664598 | Hoffmann-La Roche | Rheumatoid Arthritis | 2012-05 | PHASE3 |
| NCT02348216 | Kite, A Gilead Company | Refractory Diffuse Large B Cell Lymphoma (DLBCL)|Relapsed Diffuse Large B-Cell Lymphoma|Transformed Follicular Lymphoma (TFL)|Primary Mediastinal B-cell Lymphoma (PMBCL)|High Grade B-cell Lymphoma (HGBCL) | 2015-04-21 | PHASE1|PHASE2 |
| NCT01041248 | Children´s Hospital of Eastern Ontario | Relapsing Polychondritis | 2010-01 | NA |
| NCT03967691 | Rigshospitalet, Denmark | Obesity|Healthy | 2019-06-12 | NA |
| NCT01245452 | Patrick Durez | Rheumatoid Arthritis | 2010-05 | NA |
| NCT01007435 | Hoffmann-La Roche | Rheumatoid Arthritis | 2009-10-31 | PHASE3 |
| NCT03671018 | Hoffmann-La Roche | B-cell Non-Hodgkin Lymphoma | 2018-09-25 | PHASE1|PHASE2 |
| NCT03353259 | Oslo University Hospital | Chronic Subdural Hematoma | 2017-11-28 | PHASE2|PHASE3 |
| NCT00754559 | Hoffmann-La Roche | Rheumatoid Arthritis | 2008-08 | PHASE3 |
| NCT01741688 | Hoffmann-La Roche | Rheumatoid Arthritis | 2012-10-26 | |
| NCT04258150 | Herlev Hospital | Pancreatic Cancer | 2020-04-16 | PHASE2 |
| NCT04070781 | Columbia University|Incyte Corporation | Steroid Refractory GVHD|Graft Vs Host Disease | 2020-01-20 | PHASE1 |
| NCT02419937 | Keesler Air Force Base Medical Center | Myocardial Infarction | 2015-05 | NA |
| NCT04687540 | Rigshospitalet, Denmark | Obesity|Healthy | 2021-04-09 | NA |
| NCT01120366 | SURPRISE Study Group | Rheumatoid Arthritis | 2009-10 | PHASE4 |
| NCT00810199 | Hoffmann-La Roche | Rheumatoid Arthritis | 2009-03 | PHASE3 |
| NCT00365001 | Hoffmann-La Roche | Rheumatoid Arthritis | | PHASE1 |
| NCT04412772 | Queen´s Medical Center | COVID-19 | 2020-06-12 | PHASE3 |
| NCT01664104 | Hoffmann-La Roche | Rheumatoid Arthritis | 2012-06 | |
| NCT04678739 | M Abdur Rahim Medical College and Hospital|First Affiliated Hospital Xi´an Jiaotong University|Cox´s Bazar 250 Bed District Sadar Hospital|Chattogram General Hospital | Covid19|Covid-19 ARDS | 2020-08-15 | PHASE3 |
| NCT01705730 | Hoffmann-La Roche | Rheumatoid Arthritis | 2012-07-31 | |
| NCT04888221 | Assistance Publique - H?pitaux de Paris|Roche Chugai|Roche Pharma AG | Giant Cell Arteritis|Neurovascular Disorder | 2021-09-24 | PHASE3 |
| NCT01532869 | Hoffmann-La Roche | Sclerosis, Systemic | 2012-03 | PHASE3 |
| NCT02963402 | Fundació Institut de Recerca de l´Hospital de la Santa Creu i Sant Pau | Arthritis,Rheumatoid | 2016-11-09 | |
| NCT06297096 | National Institute of Geriatrics, Rheumatology and Rehabilitation, Poland|Medical Research Agency, Poland | Systemic Sclerosis|Interstitial Lung Disease | 2025-07-01 | PHASE3 |
| NCT06426160 | Soren Schou Olesen|Aarhus University Hospital|University of Aarhus|Viborg Regional Hospital|Stanford University|Haukeland University Hospital | Pancreatitis, Chronic | 2024-05-21 | PHASE2 |
| NCT04435717 | Hospital Universitario Ramon y Cajal | Covid19 | 2020-05-04 | PHASE2 |
| NCT05604859 | Qin Ning | Severe Fever With Thrombocytopenia Syndrome | 2022-08-19 | PHASE4 |
| NCT04313608 | Hoffmann-La Roche | B-cell Lymphoma | 2020-06-04 | PHASE1 |
| NCT07493317 | Icahn School of Medicine at Mount Sinai | Major Depressive Disorder | 2026-03-26 | PHASE2 |
| NCT01194414 | Hoffmann-La Roche | Rheumatoid Arthritis | 2010-09 | PHASE3 |
| NCT02031471 | Hoffmann-La Roche | Rheumatoid Arthritis | 2014-01 | PHASE3 |
| NCT02046603 | Hoffmann-La Roche | Rheumatoid Arthritis | 2014-03-04 | PHASE3 |
| NCT05232396 | Beijing VDJBio Co., LTD. | Rheumatoid Arthritis | 2021-03-02 | PHASE1 |
| NCT03699631 | Medical College of Wisconsin|National Heart, Lung, and Blood Institute (NHLBI)|National Cancer Institute (NCI) | Hematologic Malignancy | 2018-11-06 | PHASE2 |
| NCT04412291 | Karolinska University Hospital|Karolinska Institutet | Covid-19 | 2020-06-11 | PHASE2 |
| NCT02057770 | Washington University School of Medicine | Leukemia, Myeloid, Acute | 2014-02-28 | PHASE1 |
| NCT05181397 | Peking Union Medical College Hospital | Rapid Progressive Interstitial Lung Diseases | 2021-02-22 | PHASE2 |
| NCT07254637 | Assistance Publique - H?pitaux de Paris|Fresenius AG | Calcium Pyrophosphate Deposition Disease | 2026-04 | PHASE2 |
| NCT03895879 | Reade Rheumatology Research Institute|ZonMw: The Netherlands Organisation for Health Research and Development | Rheumatoid Arthritis | 2020-03-01 | PHASE4 |
| NCT01468077 | Hoffmann-La Roche | Rheumatoid Arthritis | 2011-11 | PHASE2 |
| NCT03046381 | Karoline Krause|Roche Pharma AG | Schnitzler´s Syndrome | 2017-07-19 | PHASE2 |
| NCT00887341 | Hoffmann-La Roche | Rheumatoid Arthritis | 2009-05 | PHASE2 |
| NCT04372186 | Genentech, Inc. | COVID-19 Pneumonia | 2020-05-14 | PHASE3 |
| NCT05207670 | Genentech, Inc. | Non-Hodgkin Lymphoma | 2022-02-01 | PHASE2 |
| NCT05133635 | Marmara University | COVID-19 Virus Infection|Cytokine Storm|Corticosteroid|Tocilizumab | 2021-02-01 | PHASE4 |
| NCT02402686 | Hoffmann-La Roche | Rheumatoid Arthritis | 2015-05-20 | |
| NCT04729959 | National Cancer Institute (NCI)|NRG Oncology | Diffuse Astrocytoma, IDH-Wildtype|Recurrent Glioblastoma | 2022-03-11 | PHASE2 |
| NCT04300686 | Shanghai Zhongshan Hospital | Takayasu Arteritis|Tocilizumab|Adalimumab|Treatment | 2020-03-01 | PHASE4 |
| NCT00535782 | Hoffmann-La Roche | Rheumatoid Arthritis | 2007-10-31 | PHASE3 |
| NCT01362062 | Hoffmann-La Roche | Rheumatoid Arthritis | 2010-10-26 | |
| NCT07281027 | Yale University|Patient-Centered Outcomes Research Institute | New Onset Refractory Status Epilepticus|New-Onset Refractory Status Epilepticus|Febrile Infection-Related Epilepsy Syndrome (FIRES) | 2026-03-01 | PHASE3 |
| NCT03999749 | NYU Langone Health | Melanoma | 2019-06-11 | PHASE2 |
| NCT00754572 | Hoffmann-La Roche | Rheumatoid Arthritis | 2009-02 | PHASE3 |
| NCT04445272 | Fundacion SEIMC-GESIDA|Roche Pharma AG|Dynamic Science S.L. | COVID-19 | 2020-05-22 | PHASE2 |
| NCT01988012 | Hoffmann-La Roche | Rheumatoid Arthritis | 2014-01 | PHASE3 |
| NCT02767557 | Herlev Hospital|Celgene | Unresectable Pancreatic Carcinoma | 2017-01-26 | PHASE2 |
| NCT02901496 | Rigshospitalet, Denmark | Adiposity | 2016-08 | NA |
| NCT06430736 | Insel Gruppe AG, University Hospital Bern | Myeloma|Lymphoma|Leukemia | 2024-07-01 | PHASE2 |
| NCT00996203 | Hoffmann-La Roche | Rheumatoid Arthritis | 2009-10-31 | PHASE4 |
| NCT06033196 | National Institute of Allergy and Infectious Diseases (NIAID) | Lung Transplant | 2024-02-13 | PHASE2 |
| NCT01557374 | Assistance Publique - H?pitaux de Paris|Ministry of Health, France | Rheumatoid Arthritis | 2012-04 | PHASE4 |
| NCT05315713 | Hoffmann-La Roche | Non-Hodgkin Lymphoma, Follicular Lymphoma | 2022-05-10 | PHASE1|PHASE2 |
| NCT01183598 | Hoffmann-La Roche | Castleman´s Disease | 2006-08 | PHASE1 |
| NCT01211834 | JW Pharmaceutical | Rheumatoid Arthritis | 2009-10 | PHASE3 |
| NCT00720798 | Hoffmann-La Roche | Rheumatoid Arthritis | 2005-09 | PHASE3 |
| NCT01462162 | Hoffmann-La Roche | Rheumatoid Arthritis | 2011-09 | |
| NCT04560205 | Lahore General Hospital | SARS-CoV Infection | 2020-05-01 | PHASE1 |
| NCT04331795 | University of Chicago | COVID-19 | 2020-04-04 | PHASE2 |
| NCT00977106 | Hoffmann-La Roche | Rheumatoid Arthritis | 2009-06 | PHASE3 |
| NCT04338685 | Hoffmann-La Roche | Carcinoma, Hepatocellular|Biliary Tract Cancer|Secondary Liver Cancer|Liver Metastases | 2020-07-16 | PHASE1 |
| NCT02324257 | Hoffmann-La Roche | Solid Tumors | 2014-12-30 | PHASE1 |
| NCT00891020 | Hoffmann-La Roche | Rheumatoid Arthritis | 2009-05 | PHASE3 |
| NCT04377659 | Memorial Sloan Kettering Cancer Center | COVID-19 | 2020-05-01 | PHASE2 |
| NCT01418989 | Hoffmann-La Roche | Healthy Volunteer | 2011-07 | PHASE1 |
| NCT01637532 | Leiden University Medical Center|University Medical Center Groningen | Recurrent Ovarian Cancer | 2011-02 | PHASE1|PHASE2 |
| NCT02660528 | Brigham and Women´s Hospital | Major Depressive Disorder | 2016-04 | PHASE2 |
| NCT07138898 | NYU Langone Health | Rheumatic Disease | 2025-09 | PHASE2 |
| NCT03227419 | Lille Catholic University | Arthritis, Rheumatoid | 2018-01-22 | PHASE4 |
| NCT01730456 | Hoffmann-La Roche | Rheumatoid Arthritis | 2012-10 | PHASE3 |
| NCT02997956 | University of Michigan Rogel Cancer Center | Hepatocellular Carcinoma | 2017-07 | PHASE1|PHASE2 |
| NCT06447701 | Zhujiang Hospital|Shenzhen Second People´s Hospital|Central People´s Hospital of Zhanjiang|Shantou Central Hospital|Eighth Affiliated Hospital, Sun Yat-sen University|Guangzhou First People´s Hospital|Peking University Shenzhen Hospital|Guangdong Provincial People´s Hospital | Brain Diseases|Ischemic Stroke|Ischemia|Stroke|Cerebral Infarction|Atherosclerosis of Artery|Atheroscleroses, Intracranial | 2025-10-30 | PHASE3 |
| NCT04310228 | Peking University First Hospital | COVID-19 | 2020-03-08 | NA |
| NCT00773461 | Hoffmann-La Roche | Rheumatoid Arthritis | 2008-10-31 | PHASE3 |
| NCT01209702 | Hoffmann-La Roche | Spondylitis, Ankylosing | 2010-09 | PHASE3 |
| NCT01941095 | Hoffmann-La Roche | Rheumatoid Arthritis | 2013-11-20 | PHASE3 |
| NCT07573332 | University of Texas Southwestern Medical Center|Bristol-Myers Squibb | AQP4&addition; NMOSD | 2026-06-01 | PHASE1 |
| NCT03135171 | University of Michigan Rogel Cancer Center | Breast Cancer | 2017-07-26 | PHASE1 |
| NCT04088396 | Eli Lilly and Company | Systemic Juvenile Idiopathic Arthritis | 2020-02-12 | PHASE3 |
| NCT05769959 | Hoffmann-La Roche | Renal Cell Carcinoma|Non-small Cell Lung Cancer|Pancreatic Adenocarcinoma|Colorectal Cancer|Ovarian Neoplasms | 2023-06-15 | PHASE1 |
| NCT01399697 | Hoffmann-La Roche | Rheumatoid Arthritis | 2011-09 | PHASE4 |
| NCT03787290 | Massachusetts General Hospital|heckel medizintechnik GmbH | Major Depressive Disorder | 2026-12-01 | PHASE2 |
| NCT07377058 | Peking Union Medical College Hospital | Dermatomyositis | 2025-11-01 | NA |
| NCT02206035 | William R. Drobyski, MD | Hematopoietic Stem Cell Transplantation | 2014-12 | PHASE2 |
| NCT06016179 | Allegheny Singer Research Institute (also known as Allegheny Health Network Research Institute) | Malignant Pleural Effusion|Malignant Ascites | 2024-01-30 | PHASE1 |
| NCT02001987 | Hoffmann-La Roche | Rheumatoid Arthritis | 2014-01 | PHASE3 |
| NCT04688021 | Yi Luo | Leukemia|Graft-versus-host-disease | 2020-12-03 | PHASE2 |
| NCT05302947 | Pirogov Russian National Research Medical University|City Clinical Hospital No.52 of Moscow Healthcare Department | COVID-19|Mild to Moderate | 2020-02-01 | |
| NCT02809833 | Hoffmann-La Roche | Rheumatoid Arthritis | 2009-01 | |
| NCT03507348 | University Hospital, Grenoble | End-stage Renal Disease|Kidney Transplantation|Hla-incompatible Kidney Transplant Candidates | 2018-07-01 | NA |
| NCT00144664 | Chugai Pharmaceutical | Systemic Juvenile Idiopathic Arthritis | 2004-11 | PHASE3 |
| NCT05725434 | Celltrion | Rheumatoid Arthritis | 2023-02-06 | PHASE3 |
| NCT01256736 | JW Pharmaceutical | Rheumatoid Arthritis | 2010-03 | PHASE3 |
| NCT00848120 | Hoffmann-La Roche | Rheumatoid Arthritis | 2008-12-31 | PHASE3 |
| NCT01034397 | Hoffmann-La Roche | Rheumatoid Arthritis | 2010-03 | PHASE4 |
| NCT01610791 | Hoffmann-La Roche | Rheumatoid Arthritis | 2010-03 | PHASE3 |
| NCT03112213 | Hoffmann-La Roche | Rheumatoid Arthritis | 2017-01-12 | |
| NCT02469896 | Barrow Neurological Institute|ALS Association|Barrow Neurological Foundation|Massachusetts General Hospital|Genentech, Inc. | ALS|Amyotrophic Lateral Sclerosis|Lou Gehrig´s Disease|Motor Neuron Disease | 2015-11 | PHASE2 |
| NCT02678988 | Hoffmann-La Roche | Healthy Volunteer | 2016-02 | PHASE1 |
| NCT01878318 | Hoffmann-La Roche | Rheumatoid Arthritis | 2013-06 | PHASE4 |
| NCT04449224 | Hanyang University|Ministry of Health, Republic of Korea | Rheumatoid Arthritis | 2020-04-27 | |
| NCT03781310 | Tel-Aviv Sourasky Medical Center|Amsterdam Rheumatology and Immunology Center | Rheumatoid Arthritis|Tocilizumab | 2018-12 | PHASE4 |
| NCT04082910 | Chinese PLA General Hospital | Solid Tumor|Hematological Malignancy | 2019-09-15 | PHASE1|PHASE2 |
| NCT04375228 | Columbia University|Genentech, Inc. | Immune-related Adverse Events|Advanced Solid Tumor | 2020-09-25 | PHASE2 |
| NCT05535244 | Hoffmann-La Roche | Multiple Myeloma | 2022-10-17 | PHASE1|PHASE2 |
| NCT00106548 | Hoffmann-La Roche | Rheumatoid Arthritis | | PHASE3 |
| NCT02447055 | Washington University School of Medicine | Multiple Myeloma|Myeloma-Multiple | 2015-12 | EARLY_PHASE1 |
| NCT02287922 | Ablynx, a Sanofi company | Rheumatoid Arthritis | 2015-03 | PHASE2 |
| NCT03448042 | Genentech, Inc. | Solid Tumors | 2018-06-06 | PHASE1 |
| NCT03869190 | Hoffmann-La Roche|Gilead Sciences, Inc., GlaxoSmithKline plc, Seattle Genetics and Astellas | Urothelial Carcinoma|Bladder Cancer | 2019-06-01 | PHASE1|PHASE2 |
| NCT04734678 | Ain Shams University|Misr International University | Covid19|Cytokine Storm|Corona Virus Infection | 2020-12-01 | |
| NCT04115423 | Sungkyunkwan University|Ministry of Food and Drug Safety, Korea | Infection|Rheumatoid Arthritis | 2020-04-01 | |
| NCT03275103 | Genentech, Inc. | Multiple Myeloma | 2017-09-19 | PHASE1 |
| NCT00106535 | Hoffmann-La Roche | Rheumatoid Arthritis | 2005-01 | PHASE3 |
| NCT05133895 | Peking Union Medical College Hospital | Chronic Periaortitis|Tocilizumab Monotherapy | 2020-07-15 | |
| NCT03424005 | Hoffmann-La Roche|Gilead Sciences|Pfizer | Metastatic Breast Cancer | 2018-03-30 | PHASE1|PHASE2 |
| NCT07115745 | Juno Therapeutics, Inc., a Bristol-Myers Squibb Company | Refractory Autoimmune Diseases | 2025-09-04 | PHASE1 |
| NCT06251076 | University Health Network, Toronto|Janssen Inc. | Multiple Myeloma|Relapsed Cancer|Refractory Cancer | 2024-11-19 | PHASE4 |
| NCT02404558 | Sanofi|Regeneron Pharmaceuticals | Rheumatoid Arthritis | 2015-05 | PHASE1 |
| NCT07113743 | National Institute of Allergy and Infectious Diseases (NIAID) | Chronic Granulomatous Disease (CGD) | 2025-09-10 | PHASE1|PHASE2 |
| NCT04377750 | Hadassah Medical Organization|Sheba Medical Center|Wolfson Medical Center | Covid19 Pneumonia | 2020-04-08 | PHASE4 |
| NCT04345445 | University of Malaya | COVID-19 | 2020-04-15 | PHASE3 |
| NCT01987479 | Hoffmann-La Roche | Rheumatoid Arthritis | 2014-01-30 | PHASE3 |
| NCT04409262 | Hoffmann-La Roche|Gilead Sciences | COVID-19 Pneumonia | 2020-06-16 | PHASE3 |
| NCT02234960 | Hoffmann-La Roche | Rheumatoid Arthritis | 2014-08 | |
| NCT05925140 | Lebanese University|Hospital Saydet Zgharta University Medical Center | COVID-19|Hospitalized COVID-19 Patients | 2020-03-28 | PHASE1 |
| NCT01673919 | Hoffmann-La Roche | Juvenile Idiopathic Arthritis | 2012-02 | PHASE3 |
| NCT03892785 | Centre Hospitalier Universitaire Dijon | Giant Cell Arteritis | 2020-01-27 | PHASE3 |
| NCT03644667 | National Institute of Allergy and Infectious Diseases (NIAID)|PPD Development, LP | Heart Transplant | 2018-12-20 | PHASE2 |
| NCT05646836 | Genentech, Inc. | Multiple Myeloma | 2023-03-21 | PHASE1 |
| NCT06818266 | Assistance Publique - H?pitaux de Paris | Sickle Cell Disease|Acute Chest Syndrome | 2025-04 | PHASE3 |
| NCT00144651 | Chugai Pharmaceutical | Rheumatoid Arthritis | 2001-08 | PHASE2 |
| NCT01575769 | Hoffmann-La Roche | Juvenile Idiopathic Arthritis | 2012-01-19 | PHASE3 |
| NCT04910568 | Genentech, Inc.|Hoffmann-La Roche | Multiple Myeloma | 2021-07-26 | PHASE1 |
| NCT06037460 | Centre Hospitalier Universitaire Dijon | Giant Cell Arteritis | 2024-05-13 | PHASE3 |
| NCT01668966 | Hoffmann-La Roche | Rheumatoid Arthritis | 2013-12-09 | PHASE3 |
| NCT07335562 | Juno Therapeutics, Inc., a Bristol-Myers Squibb Company|Celgene Corporation | Systemic Sclerosis | 2026-04-30 | PHASE3 |
| NCT01000441 | University Hospital, Strasbourg, France | Rheumatoid Arthritis | 2009-12-23 | PHASE4 |
| NCT03522012 | Mycenax Biotech Inc. | Pharmacokinetics | 2017-10-17 | PHASE1 |
| NCT04693026 | M Abdur Rahim Medical College and Hospital|First Affiliated Hospital Xi´an Jiaotong University | Covid19|Covid-19 ARDS | 2020-09-10 | PHASE3 |
| NCT05972135 | SCRI Development Innovations, LLC|Johnson & Johnson | Multiple Myeloma | 2023-10-23 | PHASE2 |
| NCT01910038 | Centre Hospitalier Universitaire Dijon | Giant Cell Arteritis | 2013-11-08 | PHASE2 |
| NCT00862758 | University of Oklahoma|Hoffmann-La Roche | Juvenile Idiopathic Arthritis | 2009-02 | |
| NCT02511067 | University of Nebraska|Genentech, Inc. | Diabetic Macular Edema | 2016-10-01 | PHASE2 |
| NCT02049437 | Case Western Reserve University | HIV Infections | 2014-08 | PHASE1|PHASE2 |
| NCT04066114 | National Institute of Allergy and Infectious Diseases (NIAID)|Bristol-Myers Squibb|Clinical Trials in Organ Transplantation | Living-Donor Kidney Transplant|Kidney Transplant Recipients | 2019-12-11 | PHASE1|PHASE2 |
| NCT00144521 | Chugai Pharmaceutical | Rheumatoid Arthritis | 2004-02 | PHASE3 |
| NCT03923738 | Hoffmann-La Roche | Giant Cell Arteritis | 2019-08-05 | PHASE1 |
| NCT01662063 | Genentech, Inc. | Rheumatoid Arthritis | 2012-08 | PHASE3 |
| NCT03288584 | University of Athens | Rheumatoid Arthritis|Inflammation | 2017-10-27 | |
| NCT04317092 | National Cancer Institute, Naples | COVID-19 Pneumonia | 2020-03-19 | PHASE2 |
| NCT02534311 | Hoffmann-La Roche | Rheumatoid Arthritis | 2015-10-13 | |
| NCT04547062 | Nantes University Hospital | Acute Myeloid Leukemia (AML) | 2020-12-29 | PHASE1 |
| NCT04885829 | Syneos Health|Dr. Reddy´s Laboratories Limited | Rheumatoid Arthritis|Giant Cell Arteritis | 2021-05-31 | PHASE1 |
| NCT04871854 | Beni-Suef University | Breast Cancer | 2021-04-26 | PHASE2 |
| NCT03202368 | Hoffmann-La Roche | Giant Cell Arteritis | 2017-10-25 | PHASE3 |
| NCT05391750 | Emory University|National Cancer Institute (NCI) | Recurrent Plasma Cell Myeloma|Refractory Plasma Cell Myeloma | 2022-10-19 | PHASE1 |
| NCT01214733 | Hoffmann-La Roche | Rheumatoid Arthritis | 2010-10 | PHASE3 |
| NCT04730323 | FMH College of Medicine and Dentistry | Covid19 | 2020-05-12 | PHASE4 |
| NCT05171647 | Hoffmann-La Roche | Non-Hodgkin Lymphoma | 2022-04-25 | PHASE3 |
| NCT02087696 | Spanish Foundation of Rheumatology|Roche Farma, S.A | Arthritis, Rheumatoid | 2014-05 | PHASE4 |
| NCT01991990 | Hoffmann-La Roche | Healthy Volunteer | 2014-05 | PHASE4 |
| NCT04157010 | University of Leeds|Hoffmann-La Roche | Rheumatoid Arthritis | 2013-05 | PHASE4 |
| NCT07334379 | Lorenzo delSorbo|Roche Diagnostic Ltd. | Acute Hypoxemic Respiratory Failure | 2025-10-20 | PHASE2 |
| NCT01491074 | Oslo University Hospital|St. Olavs Hospital|South-Eastern Norway Regional Health Authority|University of Oslo|Norwegian University of Science and Technology | Non-ST Elevation Myocardial Infarction | 2011-08 | PHASE2 |
| NCT02385110 | M.D. Anderson Cancer Center | Leukemia | 2015-09-23 | PHASE2 |
| NCT01073826 | University of Zurich|European Foundation for the Study of Diabetes | Diabetes Mellitus, Type 2|Obesity | 2010-02 | NA |
| NCT01587989 | Hoffmann-La Roche | Rheumatoid Arthritis | 2012-02 | PHASE3 |
| NCT01119859 | Hoffmann-La Roche | Rheumatoid Arthritis | 2010-05 | PHASE4 |
| NCT01696929 | Brian Miller | Schizophrenia | 2012-09 | PHASE1 |
| NCT04893031 | Karadeniz Technical University | Tocilizumab|COVID-19|Critical Care|Mortality | 2020-03-01 | |
| NCT04423042 | University of Calgary | Covid19|COVID-19|Severe Acute Respiratory Syndrome Coronavirus 2|Coronavirus|Inflammation | 2020-07-30 | PHASE3 |
| NCT06087731 | Sun Yat-sen University | Tocilizumab|Thyroid Associated Ophthalmopathy | 2023-09-23 | PHASE2 |
| NCT01562327 | Hoffmann-La Roche | Rheumatoid Arthritis | 2012-02 | |
| NCT04332094 | Fundació Institut de Recerca de l´Hospital de la Santa Creu i Sant Pau|Instituto de Salud Carlos III | COVID-19 | 2020-04-02 | PHASE2 |
| NCT03434730 | Memorial Sloan Kettering Cancer Center | Acute Myeloid Leukemia|Acute Lymphoblastic Leukemia|Acute Leukemia|Myelodysplastic Syndromes|Myelodysplastic-Myeloproliferative Diseases|Myeloproliferative Disorder|Non Hodgkin Lymphoma|Hodgkin Lymphoma|Leukemia | 2018-02-07 | PHASE2 |
| NCT03533283 | Hoffmann-La Roche | Non-Hodgkins Lymphoma | 2018-05-08 | PHASE1|PHASE2 |
| NCT01715831 | Hoffmann-La Roche | Arthritis, Rheumatoid | 2013-01-15 | PHASE4 |
| NCT01855789 | Hoffmann-La Roche | Rheumatoid Arthritis | 2013-11-07 | PHASE3 |
| NCT04424056 | Assistance Publique Hopitaux De Marseille | Covid19 | 2020-09-01 | PHASE3 |
| NCT04246086 | Hoffmann-La Roche | Follicular Lymphoma | 2020-08-12 | PHASE1|PHASE2 |
| NCT01254331 | Hoffmann-La Roche | Rheumatoid Arthritis | 2011-02 | PHASE3 |
| NCT02929251 | Assistance Publique - H?pitaux de Paris | Uveitis|Biotherapy | 2017-06-29 | PHASE2 |
| NCT01258712 | Chugai Pharma Taiwan | Rheumatoid Arthritis (RA) | 2010-12 | PHASE3 |
| NCT04762784 | Peking Union Medical College Hospital | Idiopathic Retroperitoneal Fibrosis | 2020-07-01 | PHASE4 |
| NCT03737708 | Astellas Pharma Korea, Inc. | Rheumatoid Arthritis (RA) | 2019-02-13 | PHASE4 |
| NCT01104480 | McMaster Children´s Hospital | Relapsing Polychondritis | 2010-05 | PHASE2 |
| NCT05090410 | Atsushi Kawakami|Gilead Sciences | Rheumatoid Arthritis|JAK Inhibitor|IL-6 Inhibitor|Musculoskeletal Ultrasound|Biomarker | 2021-03-03 | PHASE3 |
| NCT01326962 | Hoffmann-La Roche | Rheumatoid Arthritis | 2011-11-30 | PHASE3 |
| NCT01251120 | Hoffmann-La Roche | Rheumatoid Arthritis | 2011-11 | PHASE4 |
| NCT05716035 | Tang-Du Hospital | Myasthenia Gravis, Generalized | 2023-04-01 | PHASE2|PHASE3 |
| NCT03970226 | University of Colorado, Denver|National Cancer Institute (NCI)|National Institutes of Health (NIH) | Adamantinomatous Craniopharyngioma | 2019-09-16 | EARLY_PHASE1 |
| NCT05833763 | Australasian Leukaemia and Lymphoma Group | Mantle Cell Lymphoma|Mantle Cell Lymphoma Refractory | 2023-10-12 | PHASE2 |
| NCT01603355 | Eric B. Suhler|Genentech, Inc. | Juvenile Idiopathic Arthritis Associated Uveitis | 2013-11 | PHASE1|PHASE2 |
| NCT04691817 | Abramson Cancer Center at Penn Medicine|Genentech, Inc. | Lung Cancer, Nonsmall Cell | 2023-07-25 | PHASE1|PHASE2 |
| NCT04370834 | National Cancer Institute (NCI) | Hematopoietic and Lymphoid Cell Neoplasm|Malignant Solid Neoplasm|Pneumonia|Pneumonitis|Severe Acute Respiratory Distress Syndrome|Symptomatic COVID-19 Infection Laboratory-Confirmed | 2020-05-28 | PHASE2 |
| NCT00965653 | Hoffmann-La Roche | Rheumatoid Arthritis | 2009-08 | PHASE1 |
| NCT06418529 | Pfizer | Rheumatoid Arthritis | 2024-05-15 | |
| NCT03588936 | Medical College of Wisconsin | Acute Leukemia|Chronic Leukemia|Lymphoma|Myelodysplastic Syndromes | 2018-09-14 | PHASE1 |
| NCT02010216 | Hoffmann-La Roche | Rheumatoid Arthritis | 2010-03 | PHASE4 |
| NCT06934044 | Hoffmann-La Roche | Multiple Myeloma | 2025-05-13 | PHASE1 |
| NCT03244709 | Hospital of Prato | Giant Cell Arteritis | 2015-01-01 | PHASE4 |
| NCT06084936 | Hoffmann-La Roche | Lymphoma | 2023-10-22 | PHASE3 |
| NCT01195272 | Hoffmann-La Roche | Rheumatoid Arthritis | 2010-08 | PHASE4 |
| NCT06452537 | Tianjin Medical University General Hospital | Myelin Oligodendrocyte Glycoprotein Antibody-associated Disease | 2024-07-09 | PHASE2|PHASE3 |
| NCT03467373 | Hoffmann-La Roche | B-Cell Lymphoma|Non-Hodgkin Lymphoma | 2018-03-13 | PHASE1 |
| NCT01441063 | National Cancer Institute (NCI) | Castleman Disease|Multicentric Castleman Disease|Giant Lymph Node Hyperplasia | 2011-09-13 | PHASE2 |
| NCT04492501 | UNICEF|Pak Emirates Military Hospital | Covid19|Cytokine Release Syndrome|Critical Illness|ARDS | 2020-04-01 | NA |
| NCT00845832 | Hoffmann-La Roche | Rheumatoid Arthritis | 2009-03 | PHASE2 |
| NCT05070247 | Takeda | Pancreatic Cancer|Hepatocellular Cancer|Mesothelioma|Breast Cancer|Gastric Cancer|Esophageal Cancer|Nasopharyngeal Cancer|Kidney Cancer|Squamous Cell Cancer of Head and Neck (SCCHN)|Non-small Cell Lung Cancer (NSCLC), Non-squamous | 2022-04-14 | PHASE1|PHASE2 |
| NCT06624085 | Hoffmann-La Roche | Lymphoma | 2025-04-28 | PHASE1 |
| NCT02353780 | Dr. Larry W. Moreland|Genentech, Inc.|Bristol-Myers Squibb | Rheumatoid Arthritis (RA) | 2015-03 | PHASE4 |
| NCT03708224 | Alain Algazi|Genentech, Inc.|American Head and Neck Society | Cancer|Carcinoma|Squamous Cell Carcinoma|Head and Neck Cancer | 2019-03-08 | PHASE2 |
| NCT02477059 | Assistance Publique - H?pitaux de Paris|Hoffmann-La Roche | Hand Osteoarthritis | 2015-11-20 | PHASE3 |
| NCT00106574 | Hoffmann-La Roche | Rheumatoid Arthritis | 2005-04 | PHASE3 |
| NCT03867617 | Thomas Wekerle|University Hospital Regensburg | Kidney Transplantation | 2019-08-01 | PHASE1|PHASE2 |
| NCT04871191 | Assistance Publique - H?pitaux de Paris|URC-CIC Paris Descartes Necker Cochin | Granulomatosis With Polyangiitis|Anti-neutrophil Cytoplasmic Antibody-associated Vasculitis | 2025-06-06 | PHASE3 |
| NCT04377503 | Hospital Sao Domingos | Cytokine Release Syndrome|Covid-19 | 2020-05-01 | PHASE2 |
| NCT03193190 | Hoffmann-La Roche | Pancreatic Adenocarcinoma | 2017-07-05 | PHASE1|PHASE2 |
| NCT04690920 | University of Lahore | Corona Virus Disease 2019 (COVID-19) | 2020-07-23 | NA |
| NCT03554161 | Wenjie Zheng | Behcet Syndrome|Uveitis | 2018-05-10 | PHASE2 |
| NCT00750880 | Hoffmann-La Roche | Rheumatoid Arthritis | 2008-09 | PHASE3 |
| NCT02874573 | Brian Miller|Brain & Behavior Research Foundation | Schizophrenia|Psychotic Disorders | 2016-09 | PHASE1 |
| NCT02735707 | UMC Utrecht|Australian and New Zealand Intensive Care Research Centre|Medical Research Institute of New Zealand|Unity Health|Berry Consultants|Global Coalition for Adaptive Research|University of Pittsburgh Medical Center|Intensive Care National Audit & Research Centre|St. Marianna University School of Medicine|Nat Intensive Care Surveillance - MORU|National University Hospital, Singapore | Community-acquired Pneumonia, Influenza, COVID-19 | 2016-04-11 | PHASE3 |
| NCT04554771 | Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)|Noordwest Ziekenhuisgroep | Esophageal Adenocarcinoma|Oesophageal Adenocarcinoma|Resectable Carcinoma | 2021-01-27 | PHASE2 |
| NCT07052058 | Hospital de Clinicas de Porto Alegre | Treatment-Resistant Major Depressive Disorder | 2025-08-25 | PHASE2 |
| NCT02046616 | Hoffmann-La Roche | Rheumatoid Arthritis | 2014-05-28 | PHASE3 |
| NCT02840175 | Assistance Publique - H?pitaux de Paris|URC-CIC Paris Descartes Necker Cochin | Juvenile Idiopathic Arthritis | 2017-05-18 | PHASE3 |
| NCT05350592 | Rigshospitalet, Denmark|Novo Nordisk A+S|Simon Spies Fonden|Helge Peetz og Verner Peetz og hustru Vilma Peetz Legat | Acute Myocardial Infarction|Cardiogenic Shock | 2022-03-13 | PHASE2 |
| NCT06624436 | Radboud University Medical Center | Sepsis|Neuroinflammatory Response|Immunosuppresion|Endotoxemia|Anakinra|Dexamethasone|Tocilizumab | 2024-10-24 | PHASE4 |
| NCT05067348 | Tang-Du Hospital | Myasthenia Gravis, Generalized | 2022-07-21 | PHASE2 |
| NCT00988221 | Hoffmann-La Roche | Juvenile Idiopathic Arthritis | 2009-11-30 | PHASE3 |
| NCT05164133 | Hoffmann-La Roche | COVID-19 | 2022-06-10 | PHASE1 |
| NCT04476979 | Assistance Publique - H?pitaux de Paris|Institut National de la Santé Et de la Recherche Médicale, France | Coronavirus Infection|SARS (Severe Acute Respiratory Syndrome)|Virus Diseases|Coronaviridae Infections|Nidovirales Infections|RNA Virus Infections|Respiratory Tract Infections|Respiratory Tract Disease | 2020-07-16 | PHASE2 |
| NCT03821246 | David Oh|Genentech, Inc.|Arcus Biosciences, Inc. | Prostate Adenocarcinoma|Prostate Cancer|Localized Prostate Cancer | 2019-10-30 | PHASE2 |
| NCT01474291 | Hoffmann-La Roche | Rheumatoid Arthritis | 2012-01 | |
| NCT05169515 | Hoffmann-La Roche | Non-Hodgkin Lymphoma | 2022-10-26 | PHASE1 |
| NCT04519385 | South Valley University | Pneumonia, Viral | 2020-03-01 | NA |
| NCT04306705 | Tongji Hospital|Hubei Xinhua Hospital|Wuhan No.1 Hospital|Wuhan Central Hospital | Covid-19|SARS|Cytokine Storm|Cytokine Release Syndrome|Tocilizumab | 2020-02-20 | |
| NCT01768572 | Sanofi|Regeneron Pharmaceuticals | Rheumatoid Arthritis | 2013-03 | PHASE3 |
| NCT01396317 | Hospital for Special Surgery, New York|Genentech, Inc. | Polymyalgia Rheumatica (PMR) | 2011-04 | PHASE2 |
| NCT02659150 | Massachusetts General Hospital|Brigham and Women´s Hospital|Genentech, Inc. | Rheumatoid Arthritis | 2016-05-18 | PHASE4 |
| NCT01667471 | Hoffmann-La Roche | Juvenile Idiopathic Arthritis | 2012-01 | PHASE3 |
| NCT04395222 | Weill Medical College of Cornell University | Hematologic Malignancy|Bone Marrow Transplant | 2020-10-07 | PHASE2 |
| NCT01283971 | Hoffmann-La Roche | Rheumatoid Arthritis | 2011-05 | PHASE4 |
| NCT04381936 | University of Oxford|UK Research and Innovation|National Institute for Health Research, United Kingdom|Wellcome Trust|Bill and Melinda Gates Foundation|Department for International Development, United Kingdom|Health Data Research UK|Medical Research Council Population Health Research Unit|NIHR Health Protection Research Unit in Emerging and Zoonotic Infections|Flu Lab | Pneumonia | 2020-03-19 | PHASE3 |
| NCT03004703 | Oslo University Hospital|St. Olavs Hospital|South-Eastern Norway Regional Health Authority|University of Oslo|Norwegian University of Science and Technology | Coronary Disease|Myocardial Infarction | 2017-03-16 | PHASE2 |
| NCT04779957 | University Hospital, Toulouse | Kidney Transplantation|Graft Failure | 2021-10-01 | PHASE2 |